Skip to main content
Premium Trial:

Request an Annual Quote

NCGR Licenses Sequence-Based Physical Mapping Method from KeyGene


The National Center for Genome Resources has licensed KeyGene’s Whole Genome Profiling physical mapping technology, the companies said earlier this month.

Under the non-exclusive agreement, NCGR can combine its in-house sequencing and informatics expertise with KeyGene’s WGP technology to produce higher quality genome assemblies.

KeyGene’s technology (IS 2/1/2011) produces short sequence tags of pooled BAC clones that are generated by its partner, Amplicon Express. It then assembles the BAC clones based on the sequence tags, resulting in a physical map that serves as a scaffold for assembling whole-genome sequence data.

NCGR President Greg May said in a statement that “many of our de novo genome projects will benefit from the WGP platform through guiding the order and orientation of our next-generation DNA sequencing-based scaffolds.”

“As a company with a focus on plant breeding, we are happy to collaborate with partners that can promote our technologies in their broader networks,” said Mark van Haaren, KeyGene’s vice president of business development. “We believe that this agreement will give a much larger customer base access to better genome assemblies that can be used as reference genomes and to support molecular breeding activities.”

The Scan

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.

Study Explores Animated Digital Message Approach to Communicate Genetic Test Results to Family Members

In the Journal of Genetic Counseling, the approach showed promise in participants presented with a hypothetical scenario related to a familial hereditary breast and ovarian cancer syndrome diagnosis.

Computational Tool Predicts Mammalian Messenger RNA Degradation Rates

A tool called Saluki, trained with mouse and human messenger RNA data, appears to improve mRNA half-life predictions by taking RNA and genetic features into account, a Genome Biology paper reports.

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.